Among the CAs known to support MCT function, it was recently shown by Ames et al. (2018) that interfering with the proteoglycan domain of CAIX reduced not only proton-coupled lactate transport but also hypoxic breast cancer cell proliferation and migration [27]. Here, CA9 is linked to breast carcinoma.